GB201400647D0 - Topical composition - Google Patents

Topical composition

Info

Publication number
GB201400647D0
GB201400647D0 GBGB1400647.2A GB201400647A GB201400647D0 GB 201400647 D0 GB201400647 D0 GB 201400647D0 GB 201400647 A GB201400647 A GB 201400647A GB 201400647 D0 GB201400647 D0 GB 201400647D0
Authority
GB
United Kingdom
Prior art keywords
topical composition
topical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1400647.2A
Other versions
GB2527726A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INNOVATE EU Ltd
Croda International PLC
Original Assignee
INNOVATE EU Ltd
Croda International PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INNOVATE EU Ltd, Croda International PLC filed Critical INNOVATE EU Ltd
Priority to GB1400647.2A priority Critical patent/GB2527726A/en
Publication of GB201400647D0 publication Critical patent/GB201400647D0/en
Publication of GB2527726A publication Critical patent/GB2527726A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
GB1400647.2A 2014-01-15 2014-01-15 Topical composition Withdrawn GB2527726A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1400647.2A GB2527726A (en) 2014-01-15 2014-01-15 Topical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1400647.2A GB2527726A (en) 2014-01-15 2014-01-15 Topical composition

Publications (2)

Publication Number Publication Date
GB201400647D0 true GB201400647D0 (en) 2014-03-05
GB2527726A GB2527726A (en) 2016-01-06

Family

ID=50238979

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1400647.2A Withdrawn GB2527726A (en) 2014-01-15 2014-01-15 Topical composition

Country Status (1)

Country Link
GB (1) GB2527726A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105902397A (en) * 2016-05-23 2016-08-31 杨正昌 Filling and sealing material containing silver polymer and application thereof in clinical dental department
FR3079745B1 (en) * 2018-04-06 2020-03-13 Sederma OIL IN WATER EMULSION FORMING A MEMORY SHAPE CREAM
US11497714B2 (en) 2020-10-06 2022-11-15 Sadat A. Al Ali Nano-carrier topical composition with vitamin D3

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4088754A (en) * 1976-03-02 1978-05-09 Research Corporation Water-soluble cerium (cerous) salts in burn therapy
EP0028110B1 (en) * 1979-10-26 1984-03-07 Smith and Nephew Associated Companies p.l.c. Autoclavable emulsions
GB0409066D0 (en) * 2004-04-23 2004-05-26 Ici Plc Surfactant composition
US9433580B2 (en) * 2011-07-21 2016-09-06 Sun Pharmaceutical Industries Limited Topical pharmaceutical composition comprising nanonized silver sulfadiazine

Also Published As

Publication number Publication date
GB2527726A (en) 2016-01-06

Similar Documents

Publication Publication Date Title
SG11201701292XA (en) Topical formulation
HK1231396A1 (en) Topical composition
SG11201704735WA (en) Composition
HK1218859A1 (en) Composition
HK1214967A1 (en) Composition
GB201403017D0 (en) Composition
HK1244432A1 (en) Composition
GB201414910D0 (en) Composition
ZA201704464B (en) Composition
GB201403561D0 (en) Composition
GB201514585D0 (en) Composition
GB201400647D0 (en) Topical composition
GB201414555D0 (en) Composition
GB201519442D0 (en) Composition
GB201522681D0 (en) Composition
GB201410493D0 (en) Composition
ZA201606127B (en) Composition
GB201513108D0 (en) Topical composition
GB201420628D0 (en) Composition
GB201415483D0 (en) Composition
GB201404390D0 (en) Composition
GB201402648D0 (en) Composition
GB201404700D0 (en) Novel Composition
IL250781A0 (en) Composition
GB201608190D0 (en) Topical composition

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)